Healthy Living/WellnessCancer Drugs Ipilimumab And Nivolumab, When Paired In Treatment, Significantly Slow Cancer Progression In Melanoma Patients A combination therapy using two drugs could improve the life expectancy of melanoma sufferers, researchers say. The doubling up of two drugs significantly slows down the progression of the disease compared to when either drug is used alone.by Jim Algar
Healthy Living/WellnessNew Drug Proposal Could Be Revolutionary For Alzheimer's Research, Treatmentby Jim Algar
Healthy Living/WellnessRat Poison in Antibiotic Pills May Have Killed at Least 13 Women in Indiaby Jim Algar
Healthy Living/WellnessIncrease in Alzheimer's disease risk linked to sleep and anxiety drugsby Jim Algar
Healthy Living/WellnessMerck’s new cancer fighter gets FDA approval, is novel 'game changer'by Jim Algar
Healthy Living/WellnessViiV, Janssen team up on new single-pill treatment for HIV patientsby Jim Algar
Healthy Living/WellnessDuchenne muscular dystrophy drug Translarna gets approved by EU regulatorsby Jim Algar